SCHEMBL4280199

SCHEMBL4280199

NCc1coc(-c2ccc(OC(F)F)c(OCc3ccccc3)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDE4B Q07343 3/20 0.41
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
PPARG P37231 3/20 0.36
PPARA Q07869 3/20 0.36
FFAR1 O14842 2/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
ALOX5AP P20292 1/20 0.35
MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19066427 1.00 TSHR (0.41) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL4284397 0.96 TSHR (0.44) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL4271714 0.89 TSHR (0.41) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL17037229 0.89 TSHR (0.41) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL17037230 0.89 TSHR (0.41) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL4279372 0.86 PDE4A (0.34) TSHRKDM4EALDH1A1MAPTHPGD
SCHEMBL4270604 0.86 TSHR (0.53) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL4278364 0.85 TSHR (0.44) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL28238622 0.85 KDM4E (0.43) TSHRKDM4EALDH1A1HSD17B10MAPT
SCHEMBL15521511 0.83 DHODH (0.37) TSHRKDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICALC., LTD. (JP) 2026-04-23 US disclosed
US-20240366573-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-11-07 US disclosed
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-05-09 US disclosed
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-08-25 US disclosed
US-20220117944-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-04-21 US disclosed
US-20200078340-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-03-12 US disclosed
US-20190070151-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-03-07 US disclosed
US-RE46792-E1 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-04-17 US disclosed
US-20170216260-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-08-03 US disclosed
EP-1954684-B1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMA CO LTD (JP) 2014-05-07 EP disclosed
US-20140100226-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-04-10 US disclosed
US-8637559-B2 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-01-28 US disclosed
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-09-03 US disclosed
EP-1954684-A2 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION Otsuka Pharmaceutical Co., Ltd. (JP) 2008-08-13 EP disclosed
WO-2007058338-A9 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMA CO LTD (JP) 2007-11-01 WO disclosed
WO-2007058338-A2 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216260-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 2109/4885KDM4E 1260/4885ALDH1A1 234/4885
US-20140100226-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 2109/4885KDM4E 1260/4885ALDH1A1 234/4885
US-20240366573-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND PDE12, PDE4B, PDE4A TSHR 4579/4885KDM4E 735/4885ALDH1A1 100/4885
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 2109/4885KDM4E 1260/4885ALDH1A1 234/4885
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE7B, PDE4B, PDE1B TSHR 1378/4885KDM4E 907/4885ALDH1A1 923/4885
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 2109/4885KDM4E 1260/4885ALDH1A1 234/4885
US-20220117944-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND PDE12, PDE4B, PDE4A TSHR 4579/4885KDM4E 735/4885ALDH1A1 100/4885
US-20200078340-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 2109/4885KDM4E 1260/4885ALDH1A1 234/4885
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 1832/4885KDM4E 1383/4885ALDH1A1 248/4885
US-20190070151-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A TSHR 2109/4885KDM4E 1260/4885ALDH1A1 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.